Amicus

is a New Jersey-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of rare diseases...
Read more
Amicus President & CEO: Bradley L Campbell

President & CEO

Bradley L Campbell

CEO Approval Rating

82/100

Annual Revenue
$528.3M
Employees
480
Funding
$1.3B
Acquisitions
3

Amicus Competitors

1Sanofi
2Takeda Pharmaceutical
3Idorsia
4Protalix
5Freeline
6Sangamo
74DMT
8Bayer
9Astellas
10Roche

Trending Companies